DatasetOpen accessZenodo
Medicaid Ketamine Therapy Coverage Database: 50-State Policy Analysis & Enrollment Data
Abstract
This file contains comprehensive coverage policy information for ketamine therapy across Medicaid plans in all 50 states (+DC), detailing coverage status, requirements, and exclusions for different ketamine formulations (Spravato nasal spray, IV, IM, and oral).
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticleMDMA
Chemsex drugs: More than ghb, mephedrone and methamphetamine?
ArticleKetamine
Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.
ArticleKetamine